FormFactor vs Photronics
FORM and PLAB side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FORM and PLAB compare
FormFactor is the larger company, worth 4.2 times as much as Photronics ($6.8B against $1.6B).
On earnings, Photronics is cheaper: it trades at 9.7× trailing earnings, against 40.0× for FormFactor.
FormFactor grew revenue faster over the last twelve months (29.1% versus 1.2% for Photronics).
Photronics keeps more of each dollar of sales as profit, with a net margin of 19.0% compared with 17.7% at FormFactor.
Photronics scores higher on the StockData Score (16 against 14 for FormFactor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FORM | PLAB |
|---|---|---|
| Size and price | ||
| Market cap | $6.8B | $1.6B |
| Share price | $87.53 | $27.55 |
| Change, 1 year | 69.5% | 22.7% |
| Change, 5 years | 104% | 95.9% |
| Beta (5Y) | 1.70 | 1.70 |
| Employees | 2,153 | 1,908 |
| StockData Score | ||
| Total score | 14 | 16 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 4 | 5 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 40.0× | 9.7× (better) |
| P/S | 7.0× | 1.9× (better) |
| P/B | 5.8× | 1.3× (better) |
| EV/EBITDA | 35.9× | 5.2× (better) |
| P/FCF | 37.7× | 14.7× (better) |
| PEG | 19.88 | 1.75 (better) |
| FCF yield | 2.7% | 6.8% (better) |
| Fair value | $74.96 | $58.44 |
| Margin of safety | −16.8% | 52.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.1% (better) | 1.2% |
| Revenue growth, 5Y average | 2.5% | 6.9% (better) |
| Net income growth (TTM) | 325% (better) | 52.2% |
| EPS growth (TTM) | 321% (better) | 61.4% |
| EPS growth, 5Y average | −7.0% | 34.4% (better) |
| Profitability | ||
| Gross margin | 47.1% (better) | 33.7% |
| Operating margin | 18.3% | 22.5% (better) |
| Net margin | 17.7% | 19.0% (better) |
| FCF margin | 18.5% (better) | 12.7% |
| Return on equity | 15.8% (better) | 13.7% |
| Return on invested capital | 20.2% | 29.2% (better) |
| Financial health | ||
| Debt / equity | 0.01 | 0.00 (better) |
| Net debt / EBITDA | −2.14 | −2.45 |
| Current ratio | 3.68 | 4.94 (better) |
| Altman Z-score | 18.24 (better) | 5.79 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 92.4% | 93.4% |
| Held by insiders | 0.87% | 3.2% |
| Insider net buying, 12 months | −$22.9M (better) | −$24.2M |
| Short interest, % of float | 3.6% | 7.1% |
Go deeper
- FORM stock overview
- FORM income statement
- FORM valuation and score
- PLAB stock overview
- PLAB income statement
- PLAB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.